BCTG Acquisition Corp.

Status: Deal Closed
U=S
Target: Tango Therapeutics; Closing Date: Aug 10, 2021
IPO Proceeds, $M $166.75M
IPO Date Sep 3, 2020
CEO Aaron I. Davis
Left Lead SVB Leerink
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare

Biotechnology in North America and Europe

IPO Geography Global
Target Company Tango Therapeutics
Deal Announced Apr 14, 2021
Deal Size, $M $352.75M
Deal Geography US/Canada
Deal Sector Healthcare
SEC Filings www.sec.gov
Closing Date Aug 10, 2021
Formerly BCTG TNGX


Sign up for Free Trial

No credit card required

Sign in for more data on BCTG Acquisition Corp.:

  • 9 directors & officers
  • 15 filings and events
  • 1 underwriters
  • 7 deal advisors
  • 2 legal advisors
  • 52 shareholders (from 13F filings)